Leonard Weinstock, MD - Inflammatory Bowel Disease I (2017 Conference) (LDN, low dose naltrexone)

 

Leonard Weinstock, MD - Inflammatory Bowel Disease I (2017 Conference) (LDN, low dose naltrexone)

The role of LDN is to improve the DNA regulation of immunity, reduce inflammation by means of endorphins reducing T- and B-cell activity, and improved vascular integrity. Biologic therapeutic agents are discussed: prednisone, 5-ASA, thiopurines, infliximab and adalimumab, vedolizumab, ustekinumab, herbs, probiotics, anti-inflammatory diets, Vitamin D, immunoglobulins. How LDN works in IBD.